When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Our long thesis on Acasti Pharma, Inc. (ACST) is built on two key pillars: 1) We see significant growth in the prescription Omega 3 (Rx OM3) drug market due to the clinically proven benefits of Rx strength OM3 used for treating hypertriglyceridemia ((HTG)), and recently shown to reduce the risk of atherosclerotic cardiovascular disease (ASCVD). 2) We believe that Acasti's drug, CaPre®, has the potential to be the "best in class" Rx OM3, enabling it to take an underappreciated share of this market even without a Cardiovascular Outcome Trial ((CVOT))